EV-based Liquid Biopsy Market Size, Share and Growth Analysis 2026 to 2035

Report Id: 1920 Pages: 180 Last Updated: 05 June 2025 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Segmentation of EV-based Liquid Biopsy Market :

EV-based Liquid Biopsy Market By Offering-

  • Kits and Assays
  • Instruments
  • Services

EV-based Liquid Biopsy Market

EV-based Liquid Biopsy Market By Workflow-

  • Sample Preparation
  • Sequencing
  • Data Analysis

EV-based Liquid Biopsy Market By Technology-

  • Isolation Technologies
    • Precipitation
    • Ultracentrifugation
    • Chromatography
  • Analysis Technologies
    • NGS
    • PCR
    • Flow Cytometry

EV-based Liquid Biopsy Market By Sample Type-

  • Blood (Plasma/Serum)
  • Urine
  • Saliva
  • Other Biofluids (CF - Cerebrospinal fluid)
  • Cell Culture

EV-based Liquid Biopsy Market By End User-

  • Academic and Research Institutions
  • Clinical Laboratories
  • Pharmaceutical and Biotechnology Companies

EV-based Liquid Biopsy Market By Region-

  • North America-
    • The US
    • Canada
  • Europe-
    • Germany
    • The UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific-
    • China
    • Japan
    • India
    • South Korea
    • South East Asia
    • Rest of Asia Pacific
  • Latin America-
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  •  Middle East & Africa-
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global EV-based Liquid Biopsy Market Snapshot

Chapter 4. Global EV-based Liquid Biopsy Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis of Metaverse Industry
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. COVID-19 Impact on Metaverse Industry

Chapter 5. Market Segmentation 1: By Offering Estimates & Trend Analysis
5.1. By Offering & Market Share, 2024-2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Offering:

5.2.1. Kits and Assays
5.2.2. Instruments
5.2.3. Services

Chapter 6. Market Segmentation 2: By Workflow Containers Estimates & Trend Analysis
6.1. By Offering & Market Share, 2024-2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Workflow Containers:

6.2.1. Sample Preparation
6.2.2. Sequencing
6.2.3. Data Analysis

Chapter 7. Market Segmentation 3: By Technology Estimates & Trend Analysis
7.1. By Offering & Market Share, 2024-2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Technology:

7.2.1. Isolation Technologies
7.2.1.1. Precipitation
7.2.1.2. Ultracentrifugation
7.2.1.3. Chromatography
7.2.2. Analysis Technologies
7.2.2.1. NGS
7.2.2.2. PCR
7.2.2.3. Flow Cytometry

Chapter 8. Market Segmentation 4: By Sample Type Estimates & Trend Analysis
8.1. By Offering & Market Share, 2024-2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Sample Type:

8.2.1. Blood (Plasma/Serum)
8.2.2. Urine
8.2.3. Saliva
8.2.4. Other Biofluids (CF - Cerebrospinal fluid)

Chapter 9. Market Segmentation 5: By End User Estimates & Trend Analysis
9.1. By Offering & Market Share, 2024-2034
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End User:

9.2.1. Academic and Research Institutions
9.2.2. Clinical Laboratories
9.2.3. Pharmaceutical and Biotechnology Companies

Chapter 10. EV-based Liquid Biopsy Market Segmentation 6: Regional Estimates & Trend Analysis

10.1. North America

10.1.1. North America EV-based Liquid Biopsy Market revenue (US$ Million) estimates and forecasts By Offering, 2021-2034
10.1.2. North America EV-based Liquid Biopsy Market revenue (US$ Million) estimates and forecasts By Workflow Containers, 2021-2034
10.1.3. North America EV-based Liquid Biopsy Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
10.1.4. North America EV-based Liquid Biopsy Market revenue (US$ Million) estimates and forecasts By, Technology 2021-2034
10.1.5. North America EV-based Liquid Biopsy Market revenue (US$ Million) estimates and forecasts By, Sample Type 2021-2034
10.1.6. North America EV-based Liquid Biopsy Market revenue (US$ Million) estimates and forecasts by country, 2021-2034

10.1.6.1. U.S.
10.1.6.2. Canada

10.2. Europe

10.2.1. Europe EV-based Liquid Biopsy Market revenue (US$ Million) by By Offering, 2021-2034
10.2.2. Europe EV-based Liquid Biopsy Market revenue (US$ Million) estimates and forecasts By Workflow Containers, 2021-2034
10.2.3. Europe EV-based Liquid Biopsy Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
10.2.4. Europe EV-based Liquid Biopsy Market revenue (US$ Million) estimates and forecasts By Technology,2021-2034
10.2.5. Europe EV-based Liquid Biopsy Market revenue (US$ Million) estimates and forecasts By Sample Type,2021-2034
10.2.6. Europe EV-based Liquid Biopsy Market revenue (US$ Million) by country, 2021-2034

10.2.6.1. Germany
10.2.6.2. Poland
10.2.6.3. France
10.2.6.4. Italy
10.2.6.5. Spain
10.2.6.6. UK
10.2.6.7. Rest of Europe

10.3. Asia Pacific

10.3.1. Asia Pacific EV-based Liquid Biopsy Market revenue (US$ Million) by Offering, 2021-2034
10.3.2. Asia Pacific EV-based Liquid Biopsy Market revenue (US$ Million) estimates and forecasts By Workflow Containers, 2021-2034
10.3.3. Asia Pacific EV-based Liquid Biopsy Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
10.3.4. Asia Pacific EV-based Liquid Biopsy Market revenue (US$ Million) estimates and forecasts By Technology, 2021-2034
10.3.5. Asia Pacific EV-based Liquid Biopsy Market revenue (US$ Million) estimates and forecasts By Sample Type, 2021-2034
10.3.6. Asia Pacific EV-based Liquid Biopsy Market revenue (US$ Million) by country, 2021-2034

10.3.6.1. China
10.3.6.2. India
10.3.6.3. Japan
10.3.6.4. Australia
10.3.6.5. Rest of Asia Pacific


10.4. Latin America

10.4.1. Latin America EV-based Liquid Biopsy Market revenue (US$ Million) by By Offering, 2021-2034
10.4.2. Latin America EV-based Liquid Biopsy Market revenue (US$ Million) estimates and forecasts By Workflow Containers, 2021-2034
10.4.3. Latin America EV-based Liquid Biopsy Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
10.4.4. Latin America EV-based Liquid Biopsy Market revenue (US$ Million) estimates and forecasts By Technology, 2021-2034
10.4.5. Latin America EV-based Liquid Biopsy Market revenue (US$ Million) estimates and forecasts By Sample Type, 2021-2034
10.4.6. Latin America EV-based Liquid Biopsy Market revenue (US$ Million) by country, (US$ Million) 2021-2034

10.4.6.1. Brazil
10.4.6.2. Rest of Latin America

10.5. Middle East & Africa

10.5.1. Middle East & Africa EV-based Liquid Biopsy Market revenue (US$ Million) by By Offering, (US$ Million)
10.5.2. Middle East & Africa EV-based Liquid Biopsy Market revenue (US$ Million) estimates and forecasts By Workflow Containers, 2021-2034
10.5.3. Middle East & Africa EV-based Liquid Biopsy Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
10.5.4. Middle East & Africa EV-based Liquid Biopsy Market revenue (US$ Million) estimates and forecasts By Technology, 2021-2034
10.5.5. Middle East & Africa EV-based Liquid Biopsy Market revenue (US$ Million) estimates and forecasts By Sample Type, 2021-2034
10.5.6. Middle East & Africa EV-based Liquid Biopsy Market revenue (US$ Million) by country, (US$ Million) 2021-2034

10.5.6.1. South Africa
10.5.6.2. GCC Countries
10.5.6.3. Rest of MEA

Chapter 11. Competitive Landscape

11.1. Major Mergers and Acquisitions/Strategic Alliances

11.2. Company Profiles

11.2.1. Abcam plc
11.2.2. AMS Biotechnology Limited (AMSBIO)
11.2.3. Bio-Techne Corporation
11.2.4. Horiba Ltd.
11.2.5. Qiagen N.V.
11.2.6. Thermo Fisher Scientific, Inc.
11.2.7. Lonza Group AG
11.2.8. Malvern Panalytical Ltd
11.2.9. Revvity, Inc. (PerkinElmer, Inc.
11.2.10. Takara Bio Inc.
11.2.11. Emerging Companies
11.2.12. Mursla Bio
11.2.13. Nanostics Inc.
11.2.14. Mercy BioAnalytics, Inc.
11.2.15. Clara Diagnostics, Inc. (Clara Biotech)
11.2.16. Other Prominent Players

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
2914
Security Code field cannot be blank!

Frequently Asked Questions

EV-based Liquid Biopsy Market Size is valued at 102.13 Million in 2024 and is predicted to reach 572.43 Million by the year 2034

EV-based Liquid Biopsy Market expected to grow at a 19.0% CAGR during the forecast period for 2025-2034

Abcam plc, AMS Biotechnology Limited (AMSBIO), Bio-Techne Corporation, Horiba Ltd., Qiagen N.V., Thermo Fisher Scientific, Inc., Lonza Group AG, Malve

EV-based Liquid Biopsy Market is segmented into offering, workflow, technology, sample type, and end user.

North America region is leading the EV-based Liquid Biopsy Market.

Report License Selection

Determine the Appropriate License for your Report

Get Sample Report Enquiry Before Buying